Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-13

Clinical Trial Update: Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 trial update showing completion of a study evaluating risedronate for osteoporosis in people with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • risedronate (risedronate)

Snippet

Sponsor: Toronto Rehabilitation Institute | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED